Lactate: A key regulator of the immune response DOI Creative Commons
Alba Llibre,

Salih Kucuk,

Atrayee Gope

et al.

Immunity, Journal Year: 2025, Volume and Issue: 58(3), P. 535 - 554

Published: March 1, 2025

SummaryLactate, the end product of both anaerobic and aerobic glycolysis in proliferating growing cells—with latter process known as Warburg effect—is historically considered a mere waste cell tissue metabolism. However, research over past ten years has unveiled multifaceted functions lactate that critically shape impact cellular biology. Beyond serving fuel source, is now to influence gene expression through histone modification function signaling molecule impacts wide range activities. These properties have been particularly studied context adaptive innate immune responses. Here, we review diverse roles regulation system during homeostasis disease pathogenesis (including cancer, infection, cardiovascular diseases, autoimmunity). Furthermore, describe recently proposed therapeutic interventions for manipulating metabolism human diseases.

Language: Английский

ABCF1-K430-Lactylation promotes HCC malignant progression via transcriptional activation of HIF1 signaling pathway DOI
Han Hong, Hexu Han,

Lei Wang

et al.

Cell Death and Differentiation, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 3, 2025

Language: Английский

Citations

0

Lactylation in health and disease: physiological or pathological? DOI Creative Commons
Lijun Zhao,

Haonan Qi,

Huiying Lv

et al.

Theranostics, Journal Year: 2025, Volume and Issue: 15(5), P. 1787 - 1821

Published: Jan. 2, 2025

Lactate is an indispensable substance in various cellular physiological functions and plays regulatory roles different aspects of energy metabolism signal transduction. Lactylation (Kla), a key pathway through which lactate exerts its functions, has been identified as novel posttranslational modification (PTM). Research indicates that Kla essential balancing mechanism variety organisms involved many biological processes pathways. closely related to disease development represents potential important new drug target. In line with existing reports, we searched for newly discovered sites on histone nonhistone proteins; reviewed the mechanisms (particularly focusing enzymes directly reversible regulation Kla, including "writers" (modifying enzymes), "readers" (modification-binding "erasers" (demodifying enzymes); summarized crosstalk between PTMs help researchers better understand widespread distribution diverse functions. Furthermore, considering "double-edged sword" role both pathological contexts, this review highlights "beneficial" states (energy metabolism, inflammatory responses, cell fate determination, development, etc.) "detrimental" pathogenic or inducive effects processes, particularly malignant tumors complex nontumor diseases. We also clarify molecular health disease, discuss feasibility therapeutic Finally, describe detection technologies their applications diagnosis clinical settings, aiming provide insights treatment diseases accelerate translation from laboratory research practice.

Language: Английский

Citations

0

Lactate-induced protein lactylation in cancer: functions, biomarkers and immunotherapy strategies DOI Creative Commons
Wenjuan Wang, Hong Wang, Qi Wang

et al.

Frontiers in Immunology, Journal Year: 2025, Volume and Issue: 15

Published: Jan. 10, 2025

Lactate, long viewed as a byproduct of glycolysis and metabolic waste. Initially identified within the context yogurt fermentation, lactate's role extends beyond culinary applications to its significance in biochemical processes. Contemporary research reveals that lactate functions not merely terminal product but also nexus for initiating physiological pathological responses body. Lysine lactylation (Kla), novel post-translational modification (PTM) proteins, has emerged pivotal mechanism by which exerts regulatory influence. This epigenetic potential alter gene expression patterns, thereby impacting Increasing evidence indicates correlation between adverse prognosis various malignancies. Consequently, this review article aims encapsulate proteins interact with lactate, elucidate tumorigenesis progression, explore therapeutic targets afforded modulation lactylation. The objective is clarify oncogenic provide strategic framework future directions burgeoning field.

Language: Английский

Citations

0

Current and future perspectives of lysine lactylation in cancer DOI
Sijia Li, Li Dong,

Kui Wang

et al.

Trends in Cell Biology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

0

Diagnostic value of a lactylation-related gene signature in hepatocellular carcinoma DOI Open Access

Jiajia Zhang,

Chunmei Dong,

Lili Wu

et al.

Translational Cancer Research, Journal Year: 2025, Volume and Issue: 14(1), P. 296 - 312

Published: Jan. 1, 2025

The occurrence rate of liver cancer is increasing in recent years. significance lactylation tumor cells should not be neglected. This study aimed to discover a gene signature related that can used for diagnostic applications. Data were downloaded from Cancer Genome Atlas (TCGA), GSE14520, GSE84402, and GSE62232 datasets. Differential analysis random forest performed hepatocellular carcinoma (HCC). Receiver operating characteristic (ROC) curve was evaluate efficiency, logistic regression established obtain the risk score equation. Besides, expression genes identified by TCGA database verified real-time quantitative polymerase chain reaction (RT-PCR). In order analyze prognostic performance, patients diagnosed with HCC stratified into either high or low categories based on median score. addition, immunotherapy drug sensitivity groups assessed. performance model validated Gene Expression Omnibus (GEO) dataset. had worse outcomes than those database. ROC curves showed characteristics lactylation-related good predictive capability. Furthermore, we developed nomogram patients, utilizing data resources TCGA. Finally, terms assessing potency group lower Tumor Immune Dysfunction Exclusion (TIDE) score, indicating response immunotherapy. Our identification associated presents promising avenue development targeted immunotherapeutic strategies.

Language: Английский

Citations

0

Lactylation: The Metabolic Accomplice Shaping Cancer's Response to Radiotherapy and Immunotherapy DOI
Danqing Yu, Qingping Zhong, Yanlin Wang

et al.

Ageing Research Reviews, Journal Year: 2025, Volume and Issue: unknown, P. 102670 - 102670

Published: Jan. 1, 2025

Language: Английский

Citations

0

Metabolic cross-talk between glioblastoma and glioblastoma-associated microglia/macrophages: From basic insights to therapeutic strategies DOI
Yuan Gao, Mengxia Zhang, Guihua Wang

et al.

Critical Reviews in Oncology/Hematology, Journal Year: 2025, Volume and Issue: 208, P. 104649 - 104649

Published: Feb. 6, 2025

Language: Английский

Citations

0

Metabolic reprogramming shapes post-translational modification in macrophages DOI
Ziyi Han, Yishan Shen, Yuqi Yan

et al.

Molecular Aspects of Medicine, Journal Year: 2025, Volume and Issue: 102, P. 101338 - 101338

Published: Feb. 19, 2025

Language: Английский

Citations

0

Unveiling lactylation modification: A new hope for cancer treatment DOI Open Access

Yuxiang Luo,

Ning Zhang, Jiarong Ye

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2025, Volume and Issue: 184, P. 117934 - 117934

Published: Feb. 21, 2025

Language: Английский

Citations

0

The epigenetic hallmarks of immune cells in cancer DOI Creative Commons
Ji Yu, Chu Xiao, Tao Fan

et al.

Molecular Cancer, Journal Year: 2025, Volume and Issue: 24(1)

Published: March 5, 2025

Targeting the dysregulation of epigenetic mechanisms in cancer has emerged as a promising therapeutic strategy. Although significant rationale progress therapies blocking cells, how regulation shapes tumor microenvironment (TME) and establishes antitumor immunity remains less understood. Recent study focus been put on epigenetic-mediated changes fate immune including differentiation, expansion, recruitment, functionalization, exhaustion T natural killer (NK) tumor-associated macrophages (TAMs), dendritic cells (DCs), myeloid-derived suppressor (MDSCs), B within TME. Here, we review latest molecular clinical insights into DNA modifications, histone modification, epitranscriptome-related regulations shape various cancers. We also discuss opportunities for leveraging to improve immunotherapies. This provides foundations proposes future direction combination therapies.

Language: Английский

Citations

0